Metformin for the Prevention of the Metabolic Side-effects of Zyprexa
Status:
Completed
Trial end date:
2011-08-01
Target enrollment:
Participant gender:
Summary
We hypothesize that metformin co-administered with olanzapine will be well tolerated and
associated with significantly less insulin resistance, weight gain and dyslipidemia as
compared to olanzapine plus placebo.